Ultra-high volume centers result in both reduced 30-day and 90-day risk-adjusted mortality for high-grade serous ovarian cancer
Spencer, R., Hacker, K.E., Rice, L.W., Reynolds, R.K., Griggs, J., Uppal, S.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.149
Date:
June, 2017
File:
PDF, 168 KB
english, 2017